← Leaderboards
David W Riches
Va Eastern Colorado Health Care System
$16,504,063
Attributed
$17,422,810
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,422,810 · 16
VA$0 · 1
By mechanism
R01$13,719,673 · 6
P01$1,681,147 · 3
R21$876,987 · 2
P50$746,503 · 2
S10$348,500 · 1
R13$50,000 · 2
Top collaborators
- Stijn Piet Johan De Langhe4 shared
- Eric Peter Schmidt1 shared
Most similar at Va Eastern Colorado Health Care System
Same institution · by research overlap
- David Albert Schwartz$51,785,661
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisLungPreventPulmonary FibrosisFibroblastsResponseEventCellsFibrosisBaseMediatingStructure Of Parenchyma Of LungInsightCollagenMyofibroblastBleomycinLung DiseasesSignal TransductionPathogenesisIn VivoAlveolarResolutionApoptoticDiagnosis
Grant awards (57)
Targeting early events in MUC5B-driven lung injury and fibrosis$541,160
P01 · FY2025 · HL · contact PI
Alveolar Septal Fibroblast Loss and The Pathogenesis of Emphysema$0
I01 · FY2025 · VA · contact PI
Targeting early events in MUC5B-driven lung injury and fibrosis$598,827
P01 · FY2024 · HL · contact PI
Alveolar Septal Fibroblast Loss and The Pathogenesis of Emphysema$0
I01 · FY2024 · VA · contact PI
Targeting early events in MUC5B-driven lung injury and fibrosis$541,160
P01 · FY2023 · HL · contact PI
Alveolar Septal Fibroblast Loss and The Pathogenesis of Emphysema$0
I01 · FY2023 · VA · contact PI
Alveolar Septal Fibroblast Loss and The Pathogenesis of Emphysema$0
I01 · FY2022 · VA · contact PI
Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis$614,709
R01 · FY2021 · HL · contact PI
Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis$614,709
R01 · FY2020 · HL · contact PI
ARDS in the 21st Century: New Insights into Clinical and Mechanistic Heterogeneity$30,000
R13 · FY2020 · HL
Therapeutic Targeting of PTPN13 in Idiopathic Pulmonary Fibrosis$0
I01 · FY2020 · VA · contact PI
Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis$614,709
R01 · FY2019 · HL · contact PI
Therapeutic Targeting of PTPN13 in Idiopathic Pulmonary Fibrosis$0
I01 · FY2019 · VA · contact PI
Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis$614,709
R01 · FY2018 · HL · contact PI
HL-Role of c-Myc in myofibroblast differentiation in pulmonary fibrosis$425,537
R01 · FY2018 · HL
Request for a High Resolution In-Vivo Micro-CT System$348,500
S10 · FY2018 · OD · contact PI
Therapeutic Targeting of PTPN13 in Idiopathic Pulmonary Fibrosis$0
I01 · FY2018 · VA · contact PI
HL-Role of c-Myc in myofibroblast differentiation in pulmonary fibrosis$437,662
R01 · FY2017 · HL
Therapeutic Targeting of PTPN13 in Idiopathic Pulmonary Fibrosis$0
I01 · FY2017 · VA · contact PI
HL-Role of c-Myc in myofibroblast differentiation in pulmonary fibrosis$472,148
R01 · FY2016 · HL
DUSP1 as a therapeutic target in fibroproliferative acute lung injury$396,250
R01 · FY2016 · HL · contact PI
HL-Role of c-Myc in myofibroblast differentiation in pulmonary fibrosis$472,148
R01 · FY2015 · HL
DUSP1 as a therapeutic target in fibroproliferative acute lung injury$390,306
R01 · FY2015 · HL · contact PI
DUSP1 as a therapeutic target in fibroproliferative acute lung injury$388,325
R01 · FY2014 · HL · contact PI
Initial functional characterization of TRUSS-deficient mice$200,141
R21 · FY2014 · AI · contact PI
Aspen Lung Conference: Rebuilding the Injured Lung$20,000
R13 · FY2014 · HL · contact PI
DUSP1 as a therapeutic target in fibroproliferative acute lung injury$377,230
R01 · FY2013 · HL · contact PI
Initial functional characterization of TRUSS-deficient mice$239,728
R21 · FY2013 · AI · contact PI
Mechanisms of myofibroblast death in pulmonary fibrosis$401,049
R01 · FY2011 · HL · contact PI
Mechanisms of myofibroblast death in pulmonary fibrosis$522,600
R01 · FY2010 · HL · contact PI
Mechanisms of myofibroblast death in pulmonary fibrosis$390,000
R01 · FY2009 · HL · contact PI
Mechanisms of myofibroblast death in pulmonary fibrosis$121,551
R01 · FY2009 · HL · contact PI
Mechanisms of myofibroblast death in pulmonary fibrosis$390,000
R01 · FY2008 · HL · contact PI
Regulation of TNF receptor signaling and functions$369,790
R01 · FY2008 · HL · contact PI
Lung specific TNF-R1 signaling in TRUSS null mice$197,237
R21 · FY2008 · AI · contact PI
Mechanisms of myofibroblast death in pulmonary fibrosis$390,000
R01 · FY2007 · HL · contact PI
Regulation of TNF receptor signaling and functions$369,790
R01 · FY2007 · HL · contact PI
Lung specific TNF-R1 signaling in TRUSS null mice$239,881
R21 · FY2007 · AI · contact PI
Regulation of TNF receptor signaling and functions$380,835
R01 · FY2006 · HL · contact PI
Regulation of TNF receptor signaling and functions$388,166
R01 · FY2005 · HL
Mechanisms of myofibroblast survival in fibrosis$304,200
R01 · FY2005 · HL
REGULATION OF TNF RECEPTOR SIGNALING AND FUNCTIONS$346,050
R01 · FY2004 · HL
Mechanisms of myofibroblast survival in fibrosis$304,200
R01 · FY2004 · HL
REGULATION OF TNF RECEPTOR SIGNALING AND FUNCTIONS$346,050
R01 · FY2003 · HL
OSMOTIC REGULATION OF MACROPHAGES IN CYSTIC FIBROSIS$307,600
R01 · FY2003 · HL
Mechanisms of myofibroblast survival in fibrosis$304,200
R01 · FY2003 · HL
REGULATION OF TNF RECEPTOR SIGNALING AND FUNCTIONS$346,050
R01 · FY2002 · HL
OSMOTIC REGULATION OF MACROPHAGES IN CYSTIC FIBROSIS$307,600
R01 · FY2002 · HL
Mechanisms of myofibroblast survival in fibrosis$304,200
R01 · FY2002 · HL
Mechanisms of myofibroblast survival in fibrosis$288,699
P50 · FY2002 · HL
REGULATION OF TNF RECEPTOR SIGNALING AND FUNCTIONS$346,050
R01 · FY2001 · HL
OSMOTIC REGULATION OF MACROPHAGES IN CYSTIC FIBROSIS$307,600
R01 · FY2001 · HL
IFN GAMMA AND TNF ALPHA REGULATION OF FIBROGENIC GROWTH FACTORS$208,827
P50 · FY2001 · HL
Mechanisms of myofibroblast survival in fibrosis$0
P01 · FY2001 · HL
REGULATION OF TNF RECEPTOR SIGNALING AND FUNCTIONS$346,050
R01 · FY2000 · HL
OSMOTIC REGULATION OF MACROPHAGES IN CYSTIC FIBROSIS$307,600
R01 · FY2000 · HL
IFN GAMMA AND TNF ALPHA REGULATION OF FIBROGENIC GROWTH FACTORS$248,977
P50 · FY2000 · HL